Argus
•
Sep 02, 2026
AMPH: Raising target price to $24.00
Summary
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
LNTH: What does Argus have to say about LNTH?
Sep 02, 2026
•
LNTH
ANIP: Lowering target price to $68.00
Sep 02, 2026
•
ANIP
COLL: Lowering target price to $23.00
Sep 02, 2026
•
COLL
SUPN: Lowering target price to $42.00
Sep 02, 2026
•
SUPN
ACHC: Lowering target price to $30.00
Sep 02, 2026
•
ACHC
